LATEST ALERTS
This tracker outlines the ballot initiatives in the US that are likely to appear on ballot this November and will be updated periodically to keep the information up to date
The US Food and Drug Administration (FDA) recently appointed Norman Birenbaum to a top post as a senior public health adviser in the FDA’s Center for Regulatory Programs, signalling a seismic shift at the agency
In a first attempt to legalise cannabis through the federal parliament in Australia, the Greens party is in the process of drafting a law for legalisation that will be available for public consultation later this year
This report provides a detailed overview of the current regulatory framework in place in the Netherlands for hemp, cannabinoids such as CBD and cannabis
Legal hurdles impeding recreational cannabis legalisation in Mexico are expected to continue through 2024, industry members told CannIntelligence during the CannaMexico conference last month
The 8th November US midterm elections are just around the corner, and while the Republicans are favoured to win the majority, regardless of the outcome, things will change dramatically
The top European countries for importing and exporting cannabis for medical and scientific purposes covered in this report are slowly developing their frameworks with the primary goal of exporting and importing narcotics
Republicans are favoured over Democrats to take control of both chambers of US Congress in the midterm elections, but there are supporters and naysayers among both major parties when it comes to cannabis legalisation
Austria’s almost non-existent regime for the use of cannabinoids in medication has been described as “a Kafkaesque nightmare” with over-officious bureaucracy putting pointless hurdles in patients’ way
The UK Advertising Standards Authority (ASA) has taken action on CBD product marketing, targeting a series of advertorials produced by Consumer Logic Research specifically promoting two brands
Hemp products are sometimes regulated in Europe as a product made of herbs and plants that is intended for smoking. This report examines the the regulatory framework for relevant policy areas in selected countries
Canada’s cannabis industry has launched a lobbying blitz, warning that the federal government must act quickly to reduce excise duties and fees on the industry or risk many Canadian cannabis companies going out of business
US president Joe Biden has called for a scheduling review of cannabis. This report will examine the procedure, potential outcomes, and implications of this scheduling review.
Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
